Literature DB >> 19375653

Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.

Ming-Yan Chen1, Pu-Chang Lie, Zhi-Ling Li, Xing Wei.   

Abstract

OBJECTIVE: Mesenchymal stem cells (MSCs) can be isolated from umbilical cord Wharton's jelly (UC-MSC) and UC can be easily obtained, representing a noncontroversial source of MSCs. UC-MSCs are more primitive than other tissue sources. Previous studies showed that UC-MSCs were still viable and were not rejected 4 months after transplantation as xenografts without the need for immune suppression, indicating that they are favorable cell source for transplantation. In this study, UC-MSCs were induced to differentiate into endothelial-like cells and compared with bone marrow (BM)-MSCs for their endothelial differentiation potential.
MATERIALS AND METHODS: UC-MSCs and BM-MSCs were characterized for expression of MSC-specific markers and osteogenic, adipogenic, and chondrogenic differentiation. They were induced to differentiate into endothelial-like cells and analyzed for expression of the endothelial-specific markers and functions.
RESULTS: UC-MSCs and BM-MSCs showed similarities in expression of the MSC-specific markers and osteogenic, adipogenic, and chondrogenic differentiation. They showed similar low-density lipoprotein-uptaking capacity following endothelial differentiation. However, UC-MSCs had higher proliferative potential than BM-MSCs. Both real-time reverse transcription polymerase chain reaction and immunocytochemical analyses demonstrated that UC-MSCs had higher expression of the endothelial-specific markers than BM-MSCs following endothelial differentiation. Both Matrigel and coculture angiogenesis assays showed that UC-MSCs and BM-MSCs after endothelial differentiation were able to form the capillary network and differentiated UC-MSCs had significantly higher total tubule length, diameter, and area than differentiated BM-MSCs.
CONCLUSION: These results showed that UC-MSCs had higher endothelial differentiation potential than BM-MSCs. Therefore, UC-MSCs are more favorable choice than BM-MSCs for neovascularization of engineered tissues.

Mesh:

Year:  2009        PMID: 19375653     DOI: 10.1016/j.exphem.2009.02.003

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  72 in total

1.  Immunomodulation of endothelial differentiated mesenchymal stromal cells: impact on T and NK cells.

Authors:  Reine El Omar; Yu Xiong; Gabriel Dostert; Huguette Louis; Monique Gentils; Patrick Menu; Jean-François Stoltz; Émilie Velot; Véronique Decot
Journal:  Immunol Cell Biol       Date:  2015-10-29       Impact factor: 5.126

2.  Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.

Authors:  Changhui Zhou; Bo Yang; Yi Tian; Hongliang Jiao; Wendi Zheng; Jian Wang; Fangxia Guan
Journal:  Cell Immunol       Date:  2011-09-29       Impact factor: 4.868

3.  CD45-CD14 +CD34 + murine bone marrow low-adherent mesenchymal primitive cells preserve multilineage differentiation potential in long-term in vitro culture.

Authors:  Krzysztof Szade; Ewa Zuba-Surma; Andrzej J Rutkowski; Alicja Jozkowicz; Jozef Dulak
Journal:  Mol Cells       Date:  2011-04-22       Impact factor: 5.034

4.  Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.

Authors:  Karen Bieback; Irena Brinkmann
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

5.  The stability evaluation of mesenchymal stem cells differentiation toward endothelial cells by chemical and mechanical stimulation.

Authors:  Elham Hasanzadeh; Ghassem Amoabediny; Nooshin Haghighipour; Nasim Gholami; Javad Mohammadnejad; Shahrokh Shojaei; Nasim Salehi-Nik
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-07-12       Impact factor: 2.416

6.  Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo.

Authors:  Julio J Mendez; Mahboobe Ghaedi; Amogh Sivarapatna; Sashka Dimitrievska; Zhen Shao; Chinedum O Osuji; Derek M Steinbacher; David J Leffell; Laura E Niklason
Journal:  Biomaterials       Date:  2014-11-26       Impact factor: 12.479

Review 7.  Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Authors:  Cun-Gang Fan; Qing-jun Zhang; Jing-ru Zhou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

8.  Model microgravity enhances endothelium differentiation of mesenchymal stem cells.

Authors:  Xiaofeng Zhang; Yayun Nan; Huan Wang; Jun Chen; Nanding Wang; Juan Xie; Jing Ma; Zongren Wang
Journal:  Naturwissenschaften       Date:  2012-12-11

9.  Recellularization potential assessment of Wharton's Jelly-derived endothelial progenitor cells using a human fetal vascular tissue model.

Authors:  Andrei Constantinescu; Eugen Andrei; Florin Iordache; Elena Constantinescu; Horia Maniu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-08-15       Impact factor: 2.416

10.  Gene expression profile of mesenchymal stem cells from paired umbilical cord units: cord is different from blood.

Authors:  Mariane Secco; Yuri B Moreira; Eder Zucconi; Natassia M Vieira; Tatiana Jazedje; Alysson R Muotri; Oswaldo K Okamoto; Sergio Verjovski-Almeida; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2009-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.